Skip to main content
Fig. 4 | Journal of Pharmaceutical Health Care and Sciences

Fig. 4

From: Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

Fig. 4

Changes in (A) BMI (mean ± SD), (B) TG (mean ± SD), (C) T-cho (mean ± SD), (D) HDL-cho (mean ± SD), and (E) LDL-cho (mean ± SD) over 288 weeks of individuals who switched from TDF to antiretroviral therapy including TAF and continued taking it. In A), B), C), D), and E), paired t-test was performed at 48 weeks (TAF48), 96 weeks (TAF96), 144 weeks (TAF144), 192 weeks (TAF192), 240 weeks (TAF240) and 288 weeks (TAF288), with TAF0 as the reference, and the significance level was set at p < 0.05

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us